Ovarian Cancer | Tumor

Living with Peace of Mind As a Two-Time Cancer Survivor

April 14th 2020, 7:00pm

A two-time survivor shares how taking action led her doctors to catch an aggressive second cancer.

Phase 3 Trial Fails to Improve Progression-Free Survival in Previously Untreated Epithelial Ovarian Cancer

April 13th 2020, 5:00pm

After failing to meet its primary endpoint of progression-free survival, the JAVELIN Ovarian PARP 100 clinical trial was stopped.

Refine and Retry, Getting Ovarian Cancer Treatment Right for Patients

April 10th 2020, 5:26pm

CURE®’s Editor-in-Chief weighs in on how the treatment and detection landscape needs to be refined to help patients with ovarian cancer.

Genetic Testing: Are Over-the-Counter Options Reliable?

April 9th 2020, 10:00pm

An expert raises her concerns about direct-to-consumer testing and shares ways people can protect themselves.

Breastfeeding Lowers the Risk of Ovarian Cancer

April 8th 2020, 5:00pm

Regardless of breastfeeding duration, women who did so after giving birth had a lower risk of developing ovarian cancer, including high-grade tumors.

Managing Ovarian Cancer Recurrence

April 6th 2020, 7:17pm

Women with ovarian cancer are living longer than ever, even those whose disease returns after initial treatment.

Survey Reveals Women Will Bear Side Effects, if a Drug Might Lengthen Life

April 4th 2020, 6:00pm

PARP inhibitors show promise in lengthening the life of women with breast cancer, and they're willing to bear the side effects of the treatment.

How PARP Inhibitors Work In Women

April 2nd 2020, 10:00pm

These targeted therapies fight disease by stopping the fix-it process in damaged cancer cells.

Understanding Risks for Breast Implant-Associated Lymphoma

February 20th 2020, 3:00am

Genetic Mutations in Men

February 20th 2020, 3:00am